212 related articles for article (PubMed ID: 26715244)
1. Insulated Foamy Viral Vectors.
Browning DL; Collins CP; Hocum JD; Leap DJ; Rae DT; Trobridge GD
Hum Gene Ther; 2016 Mar; 27(3):255-66. PubMed ID: 26715244
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the in vivo safety of insulated foamy viral vectors.
Browning DL; Everson EM; Leap DJ; Hocum JD; Wang H; Stamatoyannopoulos G; Trobridge GD
Gene Ther; 2017 Mar; 24(3):187-198. PubMed ID: 28024082
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of a clinically relevant foamy vector design in human hematopoietic repopulating cells.
Everson EM; Hocum JD; Trobridge GD
J Gene Med; 2018 Jul; 20(7-8):e3028. PubMed ID: 29935087
[TBL] [Abstract][Full Text] [Related]
4. Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.
Goodman MA; Arumugam P; Pillis DM; Loberg A; Nasimuzzaman M; Lynn D; van der Loo JCM; Dexheimer PJ; Keddache M; Bauer TR; Hickstein DD; Russell DW; Malik P
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046446
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of enhancer-blocking insulators to reduce retroviral vector genotoxicity.
Groth AC; Liu M; Wang H; Lovelett E; Emery DW
PLoS One; 2013; 8(10):e76528. PubMed ID: 24098520
[TBL] [Abstract][Full Text] [Related]
6. CTF/NF1 transcription factors act as potent genetic insulators for integrating gene transfer vectors.
Gaussin A; Modlich U; Bauche C; Niederländer NJ; Schambach A; Duros C; Artus A; Baum C; Cohen-Haguenauer O; Mermod N
Gene Ther; 2012 Jan; 19(1):15-24. PubMed ID: 21562592
[TBL] [Abstract][Full Text] [Related]
7. Development of foamy virus vectors.
Vassilopoulos G; Josephson NC; Trobridge G
Methods Mol Med; 2003; 76():545-64. PubMed ID: 12526184
[No Abstract] [Full Text] [Related]
8. Long-term follow-up of foamy viral vector-mediated gene therapy for canine leukocyte adhesion deficiency.
Bauer TR; Tuschong LM; Calvo KR; Shive HR; Burkholder TH; Karlsson EK; West RR; Russell DW; Hickstein DD
Mol Ther; 2013 May; 21(5):964-72. PubMed ID: 23531552
[TBL] [Abstract][Full Text] [Related]
9. Retargeted Foamy Virus Vectors Integrate Less Frequently Near Proto-oncogenes.
Hocum JD; Linde I; Rae DT; Collins CP; Matern LK; Trobridge GD
Sci Rep; 2016 Nov; 6():36610. PubMed ID: 27812034
[TBL] [Abstract][Full Text] [Related]
10. Large animal models for foamy virus vector gene therapy.
Trobridge GD; Horn PA; Beard BC; Kiem HP
Viruses; 2012 Dec; 4(12):3572-88. PubMed ID: 23223198
[TBL] [Abstract][Full Text] [Related]
11. Foamy viral vector integration sites in SCID-repopulating cells after MGMTP140K-mediated in vivo selection.
Olszko ME; Adair JE; Linde I; Rae DT; Trobridge P; Hocum JD; Rawlings DJ; Kiem HP; Trobridge GD
Gene Ther; 2015 Jul; 22(7):591-5. PubMed ID: 25786870
[TBL] [Abstract][Full Text] [Related]
12. FV Vectors as Alternative Gene Vehicles for Gene Transfer in HSCs.
Simantirakis E; Tsironis I; Vassilopoulos G
Viruses; 2020 Mar; 12(3):. PubMed ID: 32204324
[TBL] [Abstract][Full Text] [Related]
13. Foamy virus vectors expressing anti-HIV transgenes efficiently block HIV-1 replication.
Taylor JA; Vojtech L; Bahner I; Kohn DB; Laer DV; Russell DW; Richard RE
Mol Ther; 2008 Jan; 16(1):46-51. PubMed ID: 17955023
[TBL] [Abstract][Full Text] [Related]
14. Foamy-virus-mediated gene transfer to canine repopulating cells.
Kiem HP; Allen J; Trobridge G; Olson E; Keyser K; Peterson L; Russell DW
Blood; 2007 Jan; 109(1):65-70. PubMed ID: 16968897
[TBL] [Abstract][Full Text] [Related]
15. Chicken HS4 insulators have minimal barrier function among progeny of human hematopoietic cells transduced with an HIV1-based lentiviral vector.
Uchida N; Washington KN; Lap CJ; Hsieh MM; Tisdale JF
Mol Ther; 2011 Jan; 19(1):133-9. PubMed ID: 20940706
[TBL] [Abstract][Full Text] [Related]
16. Investigating the Barrier Activity of Novel, Human Enhancer-Blocking Chromatin Insulators for Hematopoietic Stem Cell Gene Therapy.
Papayanni PG; Psatha N; Christofi P; Li XG; Melo P; Volpin M; Montini E; Liu M; Kaltsounis G; Yiangou M; Emery DW; Anagnostopoulos A; Papayannopoulou T; Huang S; Stamatoyannopoulos G; Yannaki E
Hum Gene Ther; 2021 Oct; 32(19-20):1186-1199. PubMed ID: 34477013
[TBL] [Abstract][Full Text] [Related]
17. Foamy virus vector-mediated gene correction of a mouse model of Wiskott-Aldrich syndrome.
Uchiyama T; Adriani M; Jagadeesh GJ; Paine A; Candotti F
Mol Ther; 2012 Jun; 20(6):1270-9. PubMed ID: 22215016
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors.
Trobridge G; Russell DW
J Virol; 2004 Mar; 78(5):2327-35. PubMed ID: 14963129
[TBL] [Abstract][Full Text] [Related]
19. Foamy virus as a gene transfer vector to the central nervous system.
Caprariello AV; Miller RH; Selkirk SM
Gene Ther; 2009 Mar; 16(3):448-52. PubMed ID: 19052632
[TBL] [Abstract][Full Text] [Related]
20. A small-molecule-controlled system for efficient pseudotyping of prototype foamy virus vectors.
Ho YP; Schnabel V; Swiersy A; Stirnnagel K; Lindemann D
Mol Ther; 2012 Jun; 20(6):1167-76. PubMed ID: 22472951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
